Maroon Named to New Global Aging Consortium

Joseph MaroonPittsburgh, December 1, 2022 -- Noted health and sports medicine expert Joseph Maroon, MD, has been named to a new global aging consortium, formed by Aviv Clinics, to forge new paths in redefining healthy aging by developing and sharing cutting-edge research and treatments. 

Joining Dr. Maroon on the consortium is Michael Roizen, MD; Nir Barzilai, MD; Eric Verdin, MD; and Shai Efrati, MD. Together they have produced hundreds of research papers, and are now planning to put those findings into practice. Their collective goal is to help people live longer, healthier, happier and more productive lives by focusing on disease prevention and maximizing pathways to health.

“I know how achievable this is because I’ve lived it,” said Dr. Maroon. “I’m healthier, more content, and remain very productive in my 80’s as I was in my 50’s. As a group, and by example, we can accelerate the adoption of what we know works and make it available and accessible to everyone.”

“This effort is part of a wave of researchers who are working together to target healthspan and aging to prevent diseases and not just treat them when they appear,” said Dr. Nir Barzilai. “Aging can be modulated, and even prevented.”

“Over the past 25 years we’ve seen a dramatic acceleration of our understanding of the aging process,” said Dr. Eric Verdin. “We’re now at a crucial transition period where we can take all of this knowledge and start deploying it in humans. We now have the potential to intervene directly in the human aging process.”

Aviv Clinics specializes in the research and treatment of age-related cognitive and functional decline and novel applications of hyperbaric oxygen therapy (HBOT) to maximize human performance.

For more information on the consortium members, please visit the Aviv website.